Please login to the form below

Not currently logged in
Email:
Password:

diabetes

This page shows the latest diabetes news and features for those working in and with pharma, biotech and healthcare.

AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients

AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients

SGLT2 inhibitors – such as Farxiga (dapagliflozin) – can be used to provide organ protection for patients with chronic conditions, such as heart failure and diabetes. ... Initially, Farxiga was approved in 2014 to improve glycemic control in adults

Latest news

More from news
Approximately 359 fully matching, plus 1,393 partially matching documents found.

Latest Intelligence

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    They include: smoking, excessive alcohol consumption, diabetes, depression, hypertension, hearing impairment and mid-life obesity, in addition to a lack of social contact and physical exercise.

  • Understand, identify and partner with HCPs to improve patient support Understand, identify and partner with HCPs to improve patient support

    The International Diabetes Federation estimated that in 2019 there were around 463 million people worldwide that have diabetes. ... Diabetes consultant, Partha Kar’s Twitter account was mentioned over 250 times by his HCP peers.

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    Japan’s health system is seeing a corresponding rise in the conditions common to an ageing population, such as cardiac disease, autoimmune diseases, diabetes, osteoporosis and osteoarthritis.

  • The promise of precision medicine The promise of precision medicine

    In Qatar, research into genomics and precision medicine is being used to tackle diseases such as obesity, diabetes and cardiovascular disease. ... Diabetes is a particularly complex disease, which involves more than one gene type, and is therefore an

  • Creating strong commercial relationships in a COVID world Creating strong commercial relationships in a COVID world

    There are many potentially life-changing digital innovations on the market. For example, diabetes monitors that are applied to the skin and send patient health metrics remotely to a mobile app.

More from intelligence
Approximately 14 fully matching, plus 171 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 121 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...
Patient diversity in clinical trials
The pursuit of patient diversity in clinical trials
When all-inclusive isn’t an option, it’s an obligation...
Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?...